Establishes Bay Area Immune-Response Laboratory Capability

Bethesda, Md. and Redwood City, Calif., May 3, 2016 – Precision for Medicine, part of the Precision Medicine Group, announced today that it has acquired Applied Immunology, an established expert in the creation and delivery of custom cell-based and immunoassay solutions. Applied Immunology supports innovative and targeted therapeutics developers across all areas, ranging from immuno-oncology to rare diseases to biosimilars from research to post-approval. Applied Immunology’s client base includes some of the most pioneering new venture-backed startups, along with many major global pharmaceutical firms.

Applied Immunology strengthens and expands Precision’s specialty laboratory services in cell-based and immunoassays, and creates state-of-the-art laboratory access for Precision’s west coast biotechnology clients. Precision is an innovator in biomarker research with depth and expertise in genomics, bio-informatics, assay development, global specimen logistics, and companion diagnostics. Recently, Precision acquired ACT Oncology, the industry leader in oncology clinical trials with unparalleled experience conducting studies across all tumor types and hematology indications.

“The acquisition of Applied Immunology deepens our scientific expertise and moves us closer to our west coast clients, many of which are pursuing indications where an in-depth exploration of the immune system and immune response to drugs is paramount,” said Chad Clark, president, Precision for Medicine. “Applied Immunology has become the trusted provider of complex laboratory services for numerous innovators developing highly novel targeted therapeutics. Precision’s global laboratory infrastructure and deep expertise in oncology combined with Applied Immunology’s expertise in specialty assays creates a global solution for our customers pursuing immune therapeutics, including immuno-oncology.”

“Precision’s scale and expertise enable us to immediately offer global solutions to our customers,” said Rajiv Mahadevan, CEO of Applied Immunology. “Our clients will continue to receive access to renowned scientific talent and the customized approach on which our reputation has been built. Now we can deliver global solutions such as immune monitoring to support development needs worldwide while ensuring the same quality and scientific rigor they expect from us. We are thrilled to join the Precision family and are committed to their vision of making a meaningful impact in healthcare.”

Headquartered in Redwood City, Calif., Applied Immunology has a preeminent scientific team including noted immunogenicity expert Eugen Koren, MD, PhD, and dendritic cell biology and immunotherapy expert Anita Mehta-Damani, PhD. The combination of Precision and Applied Immunology fortifies Precision’s goal of becoming the critical solution provider to help innovative life sciences companies succeed in this new era of biomarker-driven development of novel therapies, particularly those targeting oncology and the immune system. Precision for Medicine is building the first dedicated Precision Medicine Research Organization, capitalizing on opportunities driven by dramatic advances in science and technology.

About Precision for Medicine

Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively. Precision applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology focusing predominantly around genomics, immuno-response assays, global specimen logistics, biomarker analytics, and companion diagnostics solutions. The recent addition of ACT Oncology enables Precision to provide biomarker solutions that are fully integrated with specialized oncology trials, an industry first. For more information, visit

About Applied Immunology

Applied Immunology is a specialty research laboratory with a focus on developing, validating, and implementing assay solutions. Its core area of focus includes custom cell-based assays, bioanalytical assays with a focus on biologics, and clinical immune monitoring of products in development and on the market. For more information, visit

About Precision Medicine Group Formed in 2012, the Precision Medicine Group is a specialized services company supporting next-generation approaches to drug development and commercialization. Precision provides an integrated infrastructure that supports pharmaceutical and life sciences companies as they develop new products in the age of precision medicine. The company is headquartered in Bethesda, Md., with offices throughout the US and Europe. For more information, visit

# # #

Media Contact
Randy Zane Precision for Medicine Media Relations
212-686-2650, ext. 3027